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1. Introduction 
The obstructive sleep apnea (OSA) syndrome is recognized as an independent risk factor for 
systemic hypertension. The OSA syndrome is characterized by cyclic episodes of oxygen 
desaturation due to the partial or complete obstruction of the air flow during sleep. Among 
the disturbances produced by OSA, the chronic intermittent hypoxia is considered the main 
factor for developing hypertension. Oxidative stress, inflammation, and sympathetic 
hyperactivity have been proposed as pathogenic mechanisms involved in the hypertension. 
However, evidence for a single mechanism has been difficult to establish in OSA patients, 
because of concomitant comorbidities. Since OSA patients show augmented reflex 
sympathetic, cardiovascular and ventilatory responses to acute hypoxia, it has been 
proposed that an enhance carotid body responsiveness to hypoxia is involved in the 
pathological alterations induced by OSA. This proposal has received further support, since 
studies performed in animals have shown that intermittent hypoxia selectively enhances the 
carotid body chemosensory and ventilatory responses to acute hypoxia, producing long-
term potentiation of the motor ventilatory and sympathetic discharges. The mechanisms 
underlying the enhanced carotid body chemosensory reactivity to hypoxia induced by 
intermittent hypoxia are not completely known. Nevertheless, the available evidence 
indicates that the repeated episodes of hypoxia-reoxygenation produce local oxidative stress 
in the carotid body due to the accumulation of reactive oxygen species. In this chapter, we 
will review and discuss the new evidence supporting the essential role played by the carotid 
body chemoreceptors, and the contribution of the oxidative stress, endothelin-1 and pro-
inflammatory cytokines to the progression of the cardioventilatory alterations induced by 
chronic intermittent hypoxia. 
2. The carotid body chemoreceptors 
Most of the mammalian cells respond to hypoxia modifying the expression of genes and 
proteins, which induce a physiological response to recover the tissue oxygen levels (i.e. 
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angiogenesis). However, gene expression induction is not fast enough to counteract a rapid 
drop in systemic oxygen levels. Only the peripheral chemoreceptors located in the carotid 
and aortic bodies are capable to evoke fast systemic adjustments to overcome a hypoxic 
episode. The carotid body located in the bifurcation of the carotid arteries is the main 
arterial chemoreceptor in terms of its contribution to the reflex ventilatory responses to 
hypoxia (Gonzalez et al., 1994). In humans and mammals, the carotid body initiates the 
hyperventilatory response induced by hypoxia and activates the sympathetic nervous 
system. The carotid body is a complex chemoreceptor organ with a high blood flow formed 
by different types of cells. The glomus cells are considered the oxygen sensors in the carotid 
body. Glomus cells establish synaptic contacts with the nerve terminals of the primary 
sensory neurons, whose soma are located in the petrosal ganglion (Gonzalez et al., 1994, 
Iturriaga & Alcayaga, 2004, Iturriaga et al., 2007). The current model for oxygen 
chemoreception in the carotid body states that low oxygen induced the inhibition of a 
voltage-independent potassium TASK-like current, leading to the depolarization of the 
glomus cells, followed by the entry of Ca2+ through L-type Ca2+ channels and the 
subsequent release of one or more excitatory transmitters, which in turn increase the 
discharges of action potentials in the nerve endings of the chemosensory neurons (Iturriaga 
& Alcayaga 2004, Iturriaga et al., 2007). The glomus cells contain several molecules proposed 
as putative excitatory transmitters, such as dopamine, acetylcholine, adenosine nucleotides 
and peptides. Among these molecules present in glomus cells, acetylcholine and adenosine 
triphosphate fulfill most of the criteria to be considered as the excitatory transmitters 
between the glomus cells and petrosal nerve ending (Iturriaga et al., 2007). However, other 
molecules such as dopamine, histamine, nitric oxide and endothelin-1 acts as modulators of 
the chemosensory process, acting on the glomus cells or controlling the vasomotor tone of 
the blood vessel (Iturriaga et al., 2007). More recently, it has been proposed that pro-
inflammatory cytokines, such as tumor necrosis factor-ǂ (TNF-ǂ), interleukin 6 (IL-6) and 
interleukin 1ǃ (IL-1ǃ) are excitatory modulators of the chemoreception process in the rat 
carotid body (Lam et al., 2008, Liu et al., 2009, Shu et al., 2007). 
3. Cardiovascular alterations in patients with obstructive sleep apnea and 
animals exposed to intermittent hypoxia 
The OSA syndrome, a highly prevalent sleep-breathing disorder is now recognized as an 
independent risk factor for systemic hypertension. Approximately 50% of the OSA patients 
develop systemic diurnal hypertension and 30% of the hypertensive patients have OSA. The 
OSA syndrome is also associated with stroke, pulmonary hypertension, coronary artery 
disease and atrial fibrillation (Garvey et al., 2009, Parati et al., 2007, Somers et al., 2008). The 
OSA syndrome affect up to 5% worldwide adult population, but according to the report of 
the American Heart Association in collaboration with the National Heart, Lung, and Blood 
Institute National Center on Sleep Disorders Research (Somers et al., 2008) “85% of patients 
with clinically significant and treatable OSA have never been diagnosed, and referral 
populations of OSA patients represent only the tip of the iceberg of OSA prevalence”. OSA is 
characterized by recurrent episodes of partial or complete obstruction of the air flow during 
sleep produced by the collapse of the pharyngeal airway. The interruption of the air flow 
produces hypoxia and hypercapnia, negative intrathoraxic pressure, sleep fragmentation 
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and arousal. During the airway occlusion, hypoxia and hypercapnia stimulate the carotid 
body chemoreceptors increasing the respiratory muscle effort, the vascular sympathetic tone 
and the arterial blood pressure. Finally, the stimulation of the carotid body chemoreceptors 
and probably the pulmonary mechanoreceptors elicit arousal and restores the ventilation. 
Among the disturbances produced by OSA, the exposure to intermittent hypoxia is 
considered the main factor for developing hypertension. Oxidative stress, inflammation and 
sympathetic overflow have been proposed as potential pathogenic mechanisms involved in 
the onset of the hypertension and cardiovascular diseases (Arnardottir et al., 2009, Garvey at 
al., 2009, Lavie 2003, Somers et al., 2008). However, conclusions from studies performed in 
humans are conflictive, because of concomitant effects of comorbidities (obesity, 
cardiovascular diseases, diabetes, etc) associated with OSA (Gozal & Kheirandish-Gozal, 
2008, Somer et al., 2008). Thus, animal models of chronic intermittent hypoxia (CIH), which 
simulate the hypoxic-reoxygenation cycles observed in OSA patients, reproduce several 
pathologic cardiovascular features of OSA (Fletcher et al., 1992, Pack 2009; Schulz et al., 
2008). The hypoxic-reoxygenation episodes in OSA patients enhance the cardiorespiratory 
and sympathetic responses to acute hypoxia (Carlson et al., 1993; Narkiewicz et al., 1998a, 
1998b, 1999); impair the autonomic regulation of the heart rate and the arterial blood 
pressure (Narkiewicz et al., 1999b, Shiomi et al., 1996) and exacerbate the renin-angiotensin 
system (Fletcher et al., 2002, Moller et al., 2003). Similarly, animals exposed to intermittent 
hypoxia show potentiated sympathetic discharges and vascular responses to hypoxia, and 
develop systemic hypertension (Dick et al., 2007; Fletcher et al., 1992, Greenberg et al., 1999, 
Zoccal et al., 2008). The autonomic hyperactivity is  associated with a reduction of the 
efficiency of the baroreflex control of heart rate and alterations of heart rate variability in 
OSA patients (Narkiewicz et al., 1998b, Shiomi et al., 1996) and animals exposed to 
intermittent hypoxia (Lai et al., 2006; Lin et al., 2007; Rey et al., 2004, 2008). Thus, it is likely 
that the enhanced sympathetic activity along with the reduction of the baroreflex efficiency 
would impair the regulation of heart rate and the vasomotor tone of blood vessels eliciting 
hypertension. Besides that, it has been found that intermittent hypoxia produces 
parasympathetic withdrawal, attributed in part to neuronal loss in the vagal ambiguous 
nucleus (Lin et al., 2007, Yan et al., 2008).  
4. Contribution of the carotid body to the cardiorespiratory alterations in 
obstructive sleep apnea and animal exposed to intermittent hypoxia 
Patients with recently diagnosed OSA show enhanced ventilatory, sympathetic and 
vasopressor responses to acute hypoxia, attributed to a potentiated hypoxic chemoreflex 
(Cistulli & Sullivan, 1994). Narkiewicz et al., (1999) studied the ventilatory, tachycardic and 
hypertensive responses to acute hypoxia in untreated normotensive OSA patients, and 
found that the hypoxic stimulation evokes higher ventilatory, tachycardic, and blood 
pressor responses in OSA patients than control subjects, but the ventilatory and blood 
pressor responses induced by hypercapnia and by the cold pressor tested in OSA patients 
were not different from control subjects. Loredo et al., (2001) reported that OSA 
hypertensive patients present higher basal tidal volumes, suggesting an enhanced carotid 
body chemosensory drive. Leuenberger et al., (2007) measured changes in sympathetic 
discharges recorded from the peroneal nerve of normal humans in response to acute 
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hypoxic stimulation before and after the exposure to 30 episodes of apnea. The episodes of 
apnea do not only increased sympathetic discharges and produced mild increases in arterial 
blood pressure, but also enhanced the sympathetic neural response to acute hypoxia, 
indicating that short-term intermittent hypoxia produces a facilitation of the hypoxic 
chemoreflex in normal humans. Thus, the available evidence supports the proposal that the 
enhanced oxygen chemoreflex response in OSA patients is produced by the intermittent 
hypoxia. Similarly, rats and cats exposed to chronic intermittent hypoxia show enhanced 
hypoxic ventilatory responses to acute hypoxia (Iturriaga et al., 2009, Rey et al., 2004; Reeves 
et al., 2003) and long-term facilitation of respiratory motor responses (McGuire et al., 2003, 
Dick et al., 2007, Prahbakar et al., 2005). The long-term potentiated ventilatory responses to 
acute hypoxia observed in animals exposed to intermittent hypoxia has been attributed to a 
central facilitation of the serotonin-mediated motor ventilatory output (McGuire et al., 2003). 
Although, Narkiewicz et al., (1998a, 1998b) found that sympathetic, pressor and ventilatory 
responses to acute hypoxia were enhanced in OSA patients, and Fletcher et al., (1992) 
reported that the bilateral carotid body denervation prevents the hypertension in rats 
exposed to intermittent hypoxia, the idea that carotid body chemoreceptors are involved in 
the progression of the hypertension did not receive much attention. However, new evidence 
obtained in the last decade have shown that an abnormal potentiated carotid chemosensory 
reactivity to hypoxia is crucial to potentiate the sympathetic activity (Iturriaga et al., 2005, 
2009, Feng et al., 2008, Garvey at al., 2009; Prabhakar et al., 2005, Rey et al., 2004; Smith & 
Pacchia, 2007). 
5. Intermittent hypoxia enhanced the carotid body chemosensory responses 
to acute hypoxia 
Recording of chemosensory discharges from the carotid sinus nerve have shown that 
chronic intermittent hypoxia produces long-term potentiation of the carotid body 
chemosensory responses to acute hypoxia.  Indeed, exposure of cats and rats to intermittent 
hypoxia for 4 to 10 days increases the basal carotid body chemosensory discharges 
measured in normoxia and enhances the chemosensory responses to acute hypoxia (Peng et 
al., 2003, Rey et al., 2004, Del Rio et al., 2010). Peng et al., (2003) found that the baseline 
carotid discharge and the chemosensory responses to acute hypoxia were higher in rats 
exposed to short cyclic hypoxic episodes followed by normoxia, applied during 8 hrs for 10 
days. Similarly, we found that cats exposed to intermittent hypoxia during 8 hrs for 4 days 
showed enhanced CB chemosensory and ventilatory responses to acute hypoxia (Rey et al., 
2004). In rats, we found that intermittent hypoxia for 7 days potentiates the carotid 
chemosensory responses to acute hypoxia, effect that persisted until 21 days of intermittent 
hypoxia when animals developed hypertension (Del Rio et al., 2011). Figure 1 illustrates 
representative recordings of carotid chemosensory responses induced by short hypoxic 
challenges in a sham rat and in one carotid body from a rat exposed to 5% O2, 12 times/hr 
during 8 hrs for 21 days. As is shown in fig. 1, chronic intermittent hypoxia increased the 
baseline carotid chemosensory discharges measured in normoxia and induced a 
potentiation of chemosensory responses to acute hypoxia. Since these alterations in the 
carotid chemosensory function occurred without significant elevation of the arterial blood 
pressure until 21 days of intermittent hypoxia, the hypertension was preceded by an early 
potentiation of the carotid body chemosensory and ventilatory responses to hypoxia. 
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Fig. 1. Carotid body chemosensory potentiation induced by intermittent hypoxia in the rat.  
The carotid chemosensory discharges in response to various levels of inspired O2 (FiO2 ~15 
to 5%) were measured from the carotid sinus nerve of a sham rat exposed to air to air cycles 
and a rat exposed to chronic intermittent hypoxia (CIH) for 21 days. ƒx, frequency of carotid 
chemosensory discharges, expressed in Hz. 
6. Mechanisms underlying the potentiation of carotid body chemosensory 
responses to hypoxia induced by chronic intermittent hypoxia 
The enhance carotid chemosensory responses to hypoxia has been associated to increased 
levels of reactive oxygen species (Peng et al., 2003, Iturriaga et al., 2009, Del Rio et al., 2010) 
and endothelin-1 within the CB (Rey et al., 2006, Pawar et al., 2009), but it is possible that 
pro-inflammatory cytokines, which increased in the plasma of OSA patients (Lavie 2003, 
Jelic et al., 2008) may also contributes to the enhanced carotid body chemosensory responses 
to acute hypoxia (Iturriaga et al., 2009; Del Rio et al., 2011). Although some studies 
addressed the effects of intermittent hypoxia on transmitter production and release in the 
carotid body, very little is known on the functional significance of the role played by the 
neurotransmitters in the carotid body chemosensory potentiation induced by intermittent 
hypoxia (See for review Kumar, 2011). 
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6.1 Reactive oxygen and nitrogen species  
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) have been proposed as 
mediators of the cardiovascular and cognitive morbidities in several diseases including the 
OSA syndrome (Christou et al., 2003; Gozal & Kheirandish-Gozal, 2008, Lavie 2003) and in 
pathological consequences of intermittent hypoxia in animal models (Chen et al., 2005, Del 
Rio et al., 2010, Peng et al., 2003, Peng et al., 2009). Studies performed in OSA patients and 
animals exposed to chronic intermittent hypoxia have shown that the cyclical episodes of 
hypoxia-reoxygenation produces systemic oxidative stress due to the accumulation of ROS 
and RNS, which are well known potential sources of cellular damage. Peng et al., (2003) 
found evidence that the superoxide radical participates in the potentiation of the rat carotid 
chemosensory responses to hypoxia induced by intermittent hypoxia. They found that pre-
treatment of rats for 10 days before the exposure to intermittent hypoxia with the 
superoxide dismutase mimetic, manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin 
pentachloride (MnTMPyP) prevents the potentiation of the carotid body chemosensory 
response to hypoxia. In addition, they found that intermittent hypoxia decreases the activity 
of the ROS sensitive enzyme aconitase in the whole carotid body, as well as the activity of 
the complex I of the mitochondrial electron transport chain, suggesting that the 
mitochondria is one of the sources of ROS (Peng & Prabhakar, 2003). More recently, Peng et 
al., (2009) tested the hypothesis that ROS generated by NADPH oxidase (NOX) mediate the 
intermittent hypoxia-induced carotid body potentiation. They found that acute hypoxia 
produced a larger increase in NOX activity in carotid body of rats exposed to intermittent 
hypoxia for 10 days than that of control carotid bodies. The carotid body chemosensory 
potentiation was prevented by NOX inhibitors and was not observed in NOX2 deficient 
mice. On the other hand, MacFarlane and Mitchell (2008) found that application of 
MnTMPyP into the intrathecal space of the cervical spinal cord abolished the phrenic long-
term potentiation induced by acute intermittent hypoxia in rats, suggesting that ROS 
production is needed for enhancing the phrenic nerve ventilatory discharge. Consequently, 
ROS formation seems to be necessary for respiratory plasticity induced by intermittent 
hypoxia, at the level of the carotid body and respiratory motor output. Recently, we tested 
the hypothesis that oxidative stress contributes to the carotid chemosensory potentiation 
and the progression of the hypertension in rats exposed to intermittent hypoxia (Del Rio et 
al., 2010). We hypothesized that oral supplementation of the common antioxidant ascorbic 
acid (vitamin C) may prevent the carotid chemosensory potentiation and the 
cardioventilatory alterations including the hypertension induced by the intermittent 
hypoxic exposure. Accordingly, we studied the effects of ascorbic acid supplementation in 
the drinking water (1.25 g/l) on plasma lipid peroxidation, arterial blood pressure, and 
carotid chemosensory responses to acute hypoxia in rats exposed to short hypoxic episodes 
(5% O2, 12 times/hr for 8 hrs) for 21 days (Del Rio et al., 2010). We found that exposure of 
the rats to intermittent hypoxia increased the plasma lipid peroxidation and the formation 
of 3-nitrotyrosine in the carotid body, the arterial blood pressure and enhanced the carotid 
chemosensory and ventilatory responses to hypoxia. Ascorbic acid treatment reduced the 
increased plasma lipid peroxidation and the formation of 3-nitrotyrosine in the carotid 
body, the potentiation of carotid body chemosensory responses (See Fig. 2), the ventilatory 
responses to acute hypoxia, as well as the hypertension.  
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Fig. 2. Effect of ascorbic acid on the potentiated carotid body chemosensory responses to 
hypoxia induced by intermittent hypoxia. CIH, rat exposed to intermittent hypoxia. CIH-
AA, rat exposed to intermittent hypoxia and treated with ascorbic acid. Note that ascorbic 
acid reduced both the baseline and the chemosensory response to 10% O2. ƒx, frequency of 
carotid chemosensory discharges, expressed in Hz. 
Although the current information suggests that an increased local oxidative stress 
contributes to the carotid body chemosensory potentiation induced by intermittent hypoxia, 
the direct participation of ROS on the oxygen chemotransduction process is matter of 
debate, because no chemosensory excitatory effects of ROS have been observed (Gonzalez et 
al., 2007). A possible explanation is that an increased level of the superoxide radical in the 
carotid body may reacts with nitric oxide generating peroxynitrite, a powerful oxidizing 
agent that nitrates tyrosine residues forming 3-nitrotyrosine. We already found the excessive 
formation of 3-nitrotyrosine in glomus cells and blood vessels from carotid bodies harvested 
from rats exposed to intermittent hypoxia (Del Rio et al., 2010, 2011), as is shown in fig. 3. 
The increased formation of 3-nitrotyrosine indicates that the carotid body tissue is 
continuously exposed to oxidative stress during the intermittent hypoxic exposure. In 
addition, we found that a correlation between the marked increase of 3-nitrotyrosine 
immunoreactivity in the carotid body exposed to intermittent hypoxia and the enhanced 
carotid chemosensory responses to acute hypoxia (Del Rio et al., 2011), supporting and 
extending the idea that oxidative-nitrosative stress plays a critical role in the CB 
chemosensory potentiation (Iturriaga et al., 2009, Peng & Prabhakar, 2003). In OSA patients, 
Jelic et al., (2008) found that the expression of 3-nitrotyrosine in endothelial cells was greater 
than controls subjects, indicating that the oxidative stress contributes to the endothelial 
dysfunction caused by the intermittent hypoxia. In addition to the formation of nitrotyrosine 
residues, peroxynitrites may also modify iron sulfur clusters, zinc thiolates and other 
residues. Moreover, peroxynitrites may react with inorganic molecules such as CO2 
producing other free radicals that may modify DNA, lipids or proteins.  
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Fig. 3. Exposure to CIH increased 3-nitrotyrosine formation in the glomus cells (white 
arrows) and endothelial cells (black arrows) from rat carotid bodies. Scale bar, 20 µm. 
6.2 Vasoactive molecules  
An interesting molecule, which may mediate the carotid body chemosensory potentiation 
induced by intermittent hypoxia, is endothelin-1 (ET-1). It is known that the plasmatic ET-1 
level increases in rats exposed to intermittent hypoxia (Kanagy et al., 2001) and OSA 
patients (Phillips et al., 1999). This potent vasoconstrictor peptide is expressed in the 
endothelium, blood vessels and glomus cells of the carotid body (Rey et al., 2007). The 
application of ET-1 produces chemosensory excitation in both in situ and in vitro carotid 
body perfused preparations, but not in the superfused preparation devoid of vascular 
effects (Rey & Iturriaga, 2004).  We found that ET-1 was increased locally in the carotid body 
of cats exposed to 4 days to intermittent hypoxia by ~10-fold, while ET-1 plasma levels 
remains unchanged (Rey et al., 2006). The enhanced carotid body chemosensory responses 
to hypoxia were reduced by the ET receptor blocker bosentan in the intermittent hypoxic -
treated cats, but have no effects on the carotid body chemosensory activity in control 
animals (Rey et al., 2006), indicating that a local increase of ET-1 contributes to enhance the 
carotid chemosensory responses. Pawar et al., (2009) tested the hypothesis that ET-1 induced 
by ROS plays a role in intermittent hypoxia induced chemosensory potentiation in the rat 
neonatal carotid body. They found that intermittent hypoxia enhanced the release of ET-1 
and the expression of the ET-A receptor in response to intermittent hypoxia. Systemic 
administration of MnTMPyP, which prevent the elevation of ROS, reduced the increased 
basal release of ET-1, the overexpression of ET-A receptor mRNA and the enhanced carotid 
body chemosensory response to acute hypoxia. These results support the idea that a ROS-
induced increase of ET-1 release is involved in the potentiation of carotid body 
chemosensory response elicited by intermittent hypoxia. Increased plasmatic levels of ROS 
and ET-1 have been also implicated in the hypertension induced by intermittent hypoxia. 
Troncoso-Brindeiro et al., (2007) reported that  the concurrent treatments of rats exposed to 
intermittent hypoxia with the SOD mimetic, 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl 
(TEMPOL), prevents the increased ROS plasmatic level and the hypertension. However, it is 
worth noting that intermittent hypoxia increases the expression of ET-1 in the rat CB during 
the first week of hypoxia, and later the ET-1 levels returned back to the control levels (Del 
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Rio et al., 2011), suggesting that ET-1 may contribute to the enhanced carotid body 
responsiveness to hypoxia in the early phase of the intermittent hypoxic exposures. In 
addition to the transient changes in ET-1 expression, we found a significant decrease in 
the eNOS expression in the rat carotid body at 7 days of intermittent hypoxia (Del Rio et 
al., 2011), suggesting that chronic intermittent hypoxia may decrease the nitric oxide (NO) 
levels within the carotid body. Since NO at low concentration is an inhibitory modulator 
of the carotid chemosensory activity (Iturriaga et al., 2000), a reduced NO level may 
contribute to enhance the carotid body chemosensitivity, as well as to amplify the 
vasoconstrictor effect of ET-1. This interpretation is supported by the finding that 
intermittent hypoxia decreases the expression of the neuronal NO synthase in the rat 
carotid body (Marcus et al., 2010), suggesting that the removal of the inhibitory NO effects 
may also contribute to enhance the carotid chemosensory responses to hypoxia. Our 
results also showed that carotid body iNOS immunorreactive levels increased after 21 
days of intermittent hypoxic exposure. Since iNOS produce higher amounts of NO, it is 
plausible that the NO levels in the carotid body will increase during long-term 
intermittent hypoxic exposure. It is worth noting that NO has a dual effect on carotid 
chemosensory discharges. Indeed, Iturriaga et al., (2000) found that at low levels NO is 
predominantly an inhibitor of the chemosensory discharges, whereas at high 
concentration NO increases carotid body chemosensory discharges. Thus, it is plausible 
that high NO levels in the carotid body following long-term intermittent hypoxia may 
partially contribute to maintain the carotid body chemosensory potentiation.  
6.3 Pro-inflammatory cytokines 
Endothelial dysfunction has been related to the progression of hypertension in OSA patients 
and animals exposed to intermittent hypoxia due to the increased plasmatic levels of pro-
inflammatory cytokines (Biltagi et al., 2008, Jelic et al., 2008, Jun et al., 2008, Tam et al., 2007, 
Williams & Scharf, 2007). It is likely that an increased production of ROS induced by the 
hypoxia-reoxygention cycles may evoke the expression of genes and the synthesis of pro-
inflammatory cytokines, mediated by the activation of transcription factors such as the 
nuclear factor kappa B (NF-κB), the activator protein 1 and HIF-1ǂ (Semenza & Prahbakar, 
2007). In response to oxidative stress, HIF-1ǂ induces the expression of several genes 
including ET-1 and iNOS, but ROS also produces the translocation of NF-κB to the nucleus, 
increasing the expression of several inflammatory genes such as IL-1ǃ, IL-6, TNF-ǂ, 
adhesion molecules,  iNOS and ET-1 (Janseen-Heininger et al., 2000).  Recently, we found 
that intermittent hypoxia increased the levels of TNF-ǂ and IL-1ǃ in the rat carotid body 
after 21 days of exposure (Del Rio et al, 2011). We found that glomus cells constitutively 
expresses TNF-ǂ and IL-1ǃ in the cell bodies and that chronic intermittent hypoxia up-
regulates the expression of both TNF-ǂ and IL-1ǃ, without inducing carotid body tissue 
infiltration with macrophages or changes in TNF-ǂ and IL-1ǃ plasmatic levels (Del Rio et al., 
2011). Our results showed that exposure to intermittent hypoxia enhances the rat carotid 
chemosensory responses to acute hypoxia, and progressively increase the immunorreactive 
TNF-ǂ and IL-1ǃ expression in the carotid body, suggesting a potential role for this 
cytokines in modulating the enhanced carotid body chemosensory activity after exposure to 
intermittent hypoxia. 
www.intechopen.com
 
Oxidative Stress and Diseases 
 
80
7. Proposed targets of the effects of ROS in the carotid body 
The available evidence indicates that oxidative stress mediated the potentiation of the 
carotid body chemosensory responses to acute hypoxia, induced by the exposure to 
intermittent hypoxia. However, the nature of the molecular mechanism by which ROS 
induced chemosensory potentiation is not known. Based on the presented evidences, we 
hypothesized that chronic intermittent hypoxia may increase the expression of pro-
inflammatory cytokines and other chemosensory modulators, such as ET-1 and NO, which 
may potentially contribute to enhance the carotid body chemosensory responses to hypoxia. 
Figure 4 summarized the possible targets of the effects of ROS on oxygen chemoreception in 
the carotid body. It is plausible that excessive amounts of free radicals may modify the O2-
sensitive K+ channels, increasing the intracellular Ca2+ levels, which in turn evokes the 
release of excitatory transmitters, but a direct participation of ROS on the O2 
chemotransduction process in the carotid body is not clear (Gonzalez et al., 2007).  ROS or 
other molecules, produced downstream of the ROS signal, which act upon the 
mitochondria, membrane channels or the gene expression machinery may modify the 
oxygen sensing in the carotid body. Further studies are required to determine which protein 
or enzyme complexes involved in the carotid body chemosensory process are affected by 
ROS or ROS-dependent molecules induced by intermittent hypoxia. 
 
Fig. 4. Proposed targets of the effects of ROS on the potentiation of the carotid body induced 
by intermittent hypoxia.  
8. Integrative model  
Figure 5 shown a diagram of the proposed mechanisms involved in the potentiation of the 
carotid body chemosensory responses to hypoxia induced by intermittent hypoxia, which 
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finally contributes to the development of the hypertension. We postulate that cyclic episodes 
of hypoxia-reoxygenation enhance the carotid body chemosensitivity to hypoxia, which in 
turn contributes to elicit a persistent facilitation of the sympathetic neural output. The 
enhanced sympathetic activity along with a reduction of the baroreflex efficiency should 
impair the regulation of the heart rate variability and the vasomotor tone of blood vessels, 
resulting in an elevation of arterial blood pressure. On the other hand, systemic oxidative 
stress and the inflammation per se may contribute to the endothelial dysfunction, leading to 
the hypertension. 
 
Fig. 5. Proposed mechanisms involved in the hypertension induced by the potentiation of 
the carotid body chemosensory responses to hypoxia induced by intermittent hypoxia, and 
the systemic oxidative stress.  
9. Conclusion 
Autonomic dysfunction has been associated to exposure to chronic intermittent hypoxia in 
animal models, and is thought to be involved in the increased risk of hypertension and 
cardiovascular mortality in OSA patients. The cyclic hypoxic episodes in OSA patients 
potentiate cardiovascular and sympathetic responses induced by hypoxic stimulation of 
peripheral chemoreceptors, and impair the regulation of arterial blood pressure and the 
renin–angiotensin system. Intermittent hypoxia enhances the ventilatory and cardiovascular 
responses to acute hypoxia, suggesting a major role of the carotid body in the pathological 
disfunction 
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cardiorespiratory consequences of intermittent hypoxia. New evidences indicate that 
intermittent hypoxia induced oxidative stress in the carotid body, which contributes to 
potentiate the carotid body chemosensory responses to acute hypoxia. Understanding how 
the oxidative stress interacts with the carotid body chemoreceptor system will provide new 
insights into the pathophysiological cardiovascular consequences of OSA. Thus, upcoming 
new knowledge in the field will serve to propose new therapies to moderate the severity of 
the cardiovascular alterations induced by OSA. We believe that is possible to ameliorate or 
prevent the hypertension using antioxidants, which will reduced the systemic oxidative 
stress as well as the carotid body potentiated chemosensitivity to hypoxia. 
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